InformAI

InformAI is a private Houston-based healthcare informatics and digital health company developing AI-enabled clinical software for oncology, diagnostic imaging, and transplant decision support. Its main products include RadOncAI for radiation therapy dose planning, TransplantAI for donor-recipient matching and transplant outcome prediction, and SinusAI for sinus disease detection and workflow support. The company positions its products as software-based clinical decision support and software-as-a-medical-device solutions intended to improve physician productivity, treatment planning, and patient outcomes. InformAI has been supported by venture capital and non-dilutive funding, including grants from the National Institutes of Health, the National Science Foundation, and the Cancer Prevention and Research Institute of Texas. It operates from the Texas Medical Center innovation ecosystem and collaborates with healthcare organizations, physician groups, and imaging companies.